Medicuro Virtual Health Clinic Adopts Cloud DX for Remote Patient Monitoring

Medicuro Virtual Health Clinic Adopts Cloud DX for Remote Patient Monitoring

Cloud DX (TSXV:CDX), a leading Canadian-based, North American provider of virtual care and remote patient monitoring solutions is pleased to announce a new 36-month Canadian contract for their award-winning Connected Health platform

This announcement is the latest in a series of contracts announced by Cloud DX in recent weeks, including a contract extension with a large Canadian provincial health authority and a partnership agreement with US-based Maxwell Telecare.

Newfoundland-based Medicuro Virtual Health Clinic has chosen to supply the Cloud DX Connected Health platform to patients under its care who are suffering with chronic illnesses such as congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD). Since 2019, Medicuro has served thousands of patients across Newfoundland and Labrador as one of the first online clinics operating in the province. Founder and President Dr. Todd Young along with Medicuro's team of physicians, nurses and counselors are leveraging telehealth, virtual care and now remote patient monitoring as part of a strategy to lead healthcare innovation in Newfoundland. According to the Canadian Institute of Health Information there were over 2,200 people hospitalized in the province of Newfoundland for these conditions, with each hospital stay costing over $6,000, a total annual cost of over $13 million.

Cloud DX charges upfront for Connected Health Kits that are prescribed to patients for use at home, and then charges a per patient per month fee for software, services and support as each patient enrolls in the Connected Health system.

Medicuro joins well-known healthcare providers and Cloud DX partners across Canada such as as Yukon Health & Human Services, Curatio Inc, CBI Health, VitalAire Canada, the Population Health Research Institute, Kingston Health Sciences Centre, Hamilton Health Sciences, Markham Stouffville Hospital, The Ottawa Hospital and others coast-to-coast that are relying on Cloud DX Connected Health remote patient monitoring to better support patients with chronic illnesses or those recovering at home from surgery.

About Cloud DX
Accelerating virtual healthcare's future, Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company 'World Changing Idea' finalist and one of 'Canada's Ten Most Prominent Telehealth Providers.'

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links
Twitter: https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries please contact:
Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For investor inquiries please contact:
Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

Join Cloud DX for our latest Webinar Thursday, June 24th at 11am EST: https://zoom.us/webinar/register/WN_-RFp2uY8QGO5EsnPaeK1kw

SOURCE: Cloud DX Inc.

View source version on accesswire.com:
https://www.accesswire.com/652738/Medicuro-Virtual-Health-Clinic-Adopts-Cloud-DX-for-Remote-Patient-Monitoring

News Provided by ACCESSWIRE via QuoteMedia

Cloud DX TSXV:CDX Emerging Tech Investing

ARway.ai Signs Deal with George Mason University for Augmented Reality Campus Navigation and Experience

ARway.ai ("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI powered Augmented Reality Experience platform with a disruptive no-code, no beacon spatial computing solution enabled by visual marker tracking with centimeter precision is pleased to announce that George Mason University is signed up for the ARway platform and will be deploying ten spatial maps across the university campus. The rollout is part of a 2024 project aimed at enhancing the campus navigation and campus experience for students. GMU has an undergraduate enrollment of approximately 27,014 and the campus size is 817 acres. ARway.ai is seeing demand from across the globe for University Campus deployments, and is currently deployed in the Middle East at the Suleyman Demirel University in Turkey, In the EU at the Institut für Innovations- und Informationsmanagement (iFii), University of Applied Sciences Brandenburg. ARway has also signed multiple new subscriptions with prestigious universities around the globe including Bicol University in Indonesia, DHA Suffa University in Pakistan, University of Alberta in Canada, University College Cork in the UK and German University of Technology in Oman

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Cypher Metaverse Inc. Announces Debt Settlements

Cypher Metaverse Inc. (CSE:CODE) ("CODE" or the "Company") announces today that it has entered into settlement agreements that will see $149,215 of debt settled by the issuance of 1,755,470 shares at a deemed price of $0.085, and the Company's balance sheet much improved

No finders fees will be paid. The securities issued will be subject to a four-month and one-day hold period from closing.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Nanalysis Scientific Corp. Announces Director Resignation

Nanalysis Scientific Corp. (" Nanalysis " or the " Company ", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) announces that Kham Lin has resigned as a director of the Company effective April 9, 2024 and the Board of Directors has accepted his resignation. The Company would like to thank Mr. Lin for his contributions throughout his tenure as director of the Company.

About Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1)

Nanalysis Scientific Corp. operates two primary businesses: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market.

The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.

In 2022, through its subsidiary KPrime, the Company was awarded a five-year, $160 million contract with the Government of Canada to provide maintenance services for passenger screening equipment in Canadian airports. This has resulted in the expansion of the Company's Security Services business. The Company is providing airport security equipment maintenance services for the Government of Canada in each province and territory of Canada . In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America.

Notice regarding Forward Looking Statements and Legal Disclaimer

All statements included herein, other than statements of historical fact, may be forward-looking information and such information involves various risks and uncertainties. Forward-looking information is often, but not always, identified by the use of words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia: https://www.prnewswire.com/news-releases/nanalysis-scientific-corp-announces-director-resignation-302113222.html